BioMedPartners
Switzerlandbiomedvc.com
Overview
BioMedPartners is a leading venture capital firm based in Basel, Switzerland specializing in the healthcare sector. With a primary focus on the European market, they have a diversified portfolio encompassing several sub-sectors within healthcare including IT and TMT, BioTech, FinTech and Financial Services, Medical Devices and Hospital Services, Investment Management, Life Science, and Oncology. Their investment strategy revolves around the development of new technologies and treatments with the potential to significantly improve patient health outcomes. They invest in early-to mid-stage pharmaceutical, biotechnology, diagnostics, and medical technology companies across Europe.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| iDEL Therapeutics | Mar 2026 | Seed | Lead |
| iDEL Therapeutics | Mar 2026 | Seed | Lead |
| Azafaros | May 2025 | Series B | Co-investor |
| ImmunOs Therapeutics | Sep 2024 | Series C | - |
| Cardior Pharmaceuticals | May 2024 | M&A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.